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Mucin glycoproteins with large numbers of O-linked
glycosylations comprise the mucosal barrier lining
the mammalian gastrointestinal tract from mouth to
gut. A critical biological function of mucins is to
protect the underlying epithelium from infection.
Enterohemorrhagic Escherichia coli (EHEC), the
mediator of severe food- and water-borne disease,
can breach this barrier and adhere to intestinal cells.
StcE, a 100 kDa metalloprotease secreted by
EHEC, plays a pivotal role in remodeling the mucosal
lining during infection. To obtain mechanistic insight
into its function, we have determined the structure
of StcE. Our data reveal a dynamic, multidomain
architecture featuring an unusually large substrate-
binding cleft and a prominent polarized surface
charge distribution highly suggestive of an electro-
static role in substrate targeting. The observation of
key conserved motifs in the active site allows us to
propose the structural basis for the specific recogni-
tion of a-O-glycan-containing substrates. Comple-
mentary biochemical analysis provides further
insight into its distinct substrate specificity and
binding stoichiometry.
INRODUCTION
Mucin glycoproteins in the mucosal lining of the human digestive
tract pose a significant challenge for potential pathogens that
come into contact with the surface. They spatially separate the
host epithelial cells from microorganisms in the lumen and
consist of an adherent inner layer and a dynamic outer layer
that is constantly sloughed off and renewed (reviewed in Linden
et al., 2008). Ingested microbes must first avoid agglutination by
salivary mucins and removal by mucociliary action, as well as
penetrate through a thick mucus layer masking the epithelial
cells before colonization can take place. With thickness ranging
from 70–100 mm in salivary films to 800–900 mm in the colon,
mucins form a protective physical barrier for the underlying
epithelium (reviewed in Derrien et al., 2010). Mucins are densely
glycosylated proteins characterized by Pro/Thr/Ser (PTS)-richStructure 20domains. The hydroxyls of Ser or Thr residues therein can be
modified by various O-linked glycans through the linking
sugar a-N-acetylgalactosamine (GalNAc) (reviewed in Hang
and Bertozzi, 2005) and the carbohydrate chains often occur in
clusters along the PTS tandem repeats. The high density of
oligosaccharides projecting from the peptide backbone results
in an extended, ‘‘bottle brush’’-like structure with dimensions
2.5 to 3 times greater than unglycosylated, denatured globular
proteins with similar number of residues (reviewed in Jentoft,
1990). Electrostatic repulsion and steric exclusion from the
negatively charged O-linked sugars confer protease resistance
to the mucin peptide backbone (reviewed in Van den Steen
et al., 1998) and, in turn, impede access to the host epithelium
underneath.
Enterohemorrhagic Escherichia coli of serotype O157:H7
(EHEC) is a human pathogen associated with food-borne
infections and gastrointestinal disease. These highly infectious
bacteria colonize epithelial cells in the colon and can cause
hemolytic uremic syndrome with a potentially lethal outcome
(reviewed in Nataro and Kaper, 1998). EHEC has the ability to
penetrate the mucosal lining and adhere intimately to eukaryotic
host cells but the molecular mechanisms of this process, which
is required for both colonization and infection, are only partially
understood. StcE (sercreted protease of C1-esterase inhibitor),
which EHEC secretes via the type II general secretory pathway
during infection, has been implicated to assist the penetration
step (Lathem et al., 2002; Paton and Paton, 2002). Its expression
from the pO157 virulence plasmid is activated by Ler, a global
regulator of various genes essential for EHEC pathogenesis,
including the LEE (locus of enterocyte effacement)-encoded
type III secretion system and its translocated effectors. Indeed,
Grys et al. (2005) demonstrated that StcE played a critical role
in colonization by proteolytically unmasking the host cell surface
to allow intimate adherence of EHEC to gut epithelial cells. The
decreased virulence of the Aeromonas hydrophila tagA mutant
(64% protein sequence identity with StcE) in a mouse model of
infection also supports its proposed function as a host
surface-clearing mucinase (Pillai et al., 2006). It was further
concluded that colonization defects of an EHEC type II secretion
knockout might be related to StcE deficiency (Ho et al., 2008).
The role of StcE in virulence is attributed to its zinc metallopro-
tease mediated mucinase activity toward specific mucin-type
glycoproteins. It degrades and reduces the viscosity of the
mucus layer via cleavage of mucin 7 and glycoprotein 340 pre-
sent in saliva and other tissues (Grys et al., 2005). These targets, 707–717, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 707
Table 1. Data Collection and Refinement Statistics
StcE SeMet Derivative StcE H132-N251
Data Collection
Space group C2221 H3
Mol/au 1 1
Cell dimensions
a, b, c (A˚) 76.5, 186.0, 188.8 56.0, 56.0, 96.9
a, b, g (A˚) 90.0, 90.0, 90.0 90.0, 90.0, 120.0
Resolution (A˚) 2.5 (2.56–2.50)a 1.6 (1.69–1.60)a
Total reflections 275,104 80,354
Unique reflections 47,052 14,661
Rpim
b 5.5 (36.9) 2.1 (11.3)
I/sI 9.2 (1.8) 30.3 (7.3)
Completeness (%) 100 (100) 98.9 (92.8)
Redundancy 5.8 (5.9) 5.5 (5.1)
Refinement
Rwork/Rfree 0.21/0.25 0.18/0.21
B factor (A˚2)
Protein 83 18.0
Ion 53 21.7 (7 iodides)
63 (175 molecules) 26.0 (103 molecules)
Rmsds
Bond length (A˚) 0.010 0.020
Bond angles () 1.200 1.486
Ramachandran plot
Favored (%) 95 98
Disallowed (%) 0.4 0
aMultiplicity-weighted Rmerge.
bValues in parentheses are for the highest-resolution shell.
Structure
Structure of the StcE Mucinaseform part of the innate immune system by acting as receptor
decoys for microbial adhesins to facilitate the clearance of
bacteria-protein aggregates from the host. Thus, destruction of
these defense molecules by StcE would allow EHEC to over-
come the mucosal barrier for necessary contact with the epithe-
lium to establish infection.
In addition to its role inmediating host cell colonization, StcE is
believed to contribute to immune evasion. Once attached to
colon epithelial cells, EHEC secretes various effector proteins
that lead to lesions in the endothelium and intestinal lining, and
the infiltration of leukocytes and complement proteins to the
gut lumen (reviewed in Nataro and Kaper, 1998). StcE specifi-
cally targets leukocyte surface glycoproteins CD45 and CD43,
which also contain glycosylation of the mucin type, and this
provides a further competitive advantage to the pathogen and
allows it to modulate the host immune system (Szabady et al.,
2009). In particular, the loss of these sialoglycoproteins due to
StcE proteolytic activity prevents immune cells from moving to
the sites of infection and mounting the appropriate inflammatory
response. Indeed, StcE-treated neutrophils exhibited poor
chemotactic mobility. Notably, StcE also targets the comple-
ment system, a set of proteolytically regulated plasma proteins
that form the central component of host innate immunity and
mark pathogens for destruction (reviewed in Lambris et al.,708 Structure 20, 707–717, April 4, 2012 ª2012 Elsevier Ltd All rights2008). StcE inhibits proteolytic activation of the complement
cascades by recruiting human C1-esterase inhibitor (C1-INH)
to the cell surface (Lathem et al., 2004). C1-INH is a member of
the serpin (serine protease inhibitor) family and an essential regu-
lator of serine proteases in the complement pathways. Through
specific interactions with the mucin-like N terminus of C1-INH
(Figure S1A available online), StcE localizes the complement
regulator to the cell membrane, where the C-terminal serpin
domain is then in proximity to inactivate downstream compo-
nents of the complement cascades. As a result of the inhibition,
it was shown that serum-sensitive E. coli-K12 became more
resistant to complement-mediated cell lysis in the presence of
StcE-treated C1-INH (Lathem et al., 2004).
StcE belongs to the familyM66 of zincmetalloproteases (Raw-
lings et al., 2010), which includes ToxR-activated gene A (TagA)
from the Vibrio cholera pathogenicity island, and for which no
structural information of any member is currently known. To
obtain mechanistic insight into StcE function and to understand
more fully how it subverts multiple mucosal defenses and the
complement system of innate immunity, we have carried out
X-ray crystallographic analysis of StcE and characterized its
interaction with its substrate C1-INH using complementary
biochemical and biophysical approaches.
RESULTS
Overall Structure
During EHEC infection, StcE is transported to the extracellular
milieu via the type II general secretory pathway. For our struc-
tural studies, we were able to express sufficient quantities of
the mature form of StcE devoid of its signal sequence (StcED35,
referred to hereafter as full-length StcE containing residues
36–898). Static light scattering analysis showed that full-length
StcE is monomeric and monodisperse with a measured molec-
ular mass (100 kDa) close to the expected value (Figure S1B).
After numerous attempts, we managed to obtain diffraction-
quality crystals of a catalytically inactive (E447D) and surface-
engineered mutant (K318A/K320A/E321A) of StcE and solved
the structure by the SAD method, using crystals of selenome-
thionine-incorporated protein (Table 1). Examination of the
engineered protein surface shows residues 318, 320, and 321
are distant from the active site. The alanine mutations at these
positions allowed close packing by Tyr859 from a symmetry-
related StcE molecule and this likely facilitated crystal contact
formation.
The structure of apo-StcE, refined to a resolution of 2.5 A˚,
reveals a dynamic, modular architecture with three distinct
globular domains, which we designate as IG, M, and C (Figures
1A–1C). These three domains are packed against each other and
result in an overall T-shape, with IG and M forming the arms and
C the body. The N-terminal domain IG adopts an immunoglob-
ulin-like fold that consists of complementary segments spanning
residues 57–122 and 257–287. Within domain IG, a sequence-
variable region with weak electron density, which we designate
as INS (insertion residues Lys150-Ser245), inserts between
strands 5 and 6 of the immunoglobulin b sandwich (Figures 1A
and 1B; Figure S2 sequence alignment). Immediately following
domain IG is the metalloprotease catalytic module, domain M
(Glu296-Val550). M is cradled in part by domain IG and visiblereserved
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Figure 1. StcE Overall Structure
(A–D) (A) Domain boundaries observed in the StcE structure. The two subdomains of the metalloprotease module (M-SD1 and M-SD2) are colored in green,
immunoglobulin-like domain (IG) in orange, insertion region (INS) in yellow, C-terminal domain (C) in purple and remaining disordered regions (D) in blue. SS
stands for signal sequence. (B) Secondary structure and surface representation of StcE. The color scheme matches that in (A). Catalytic residues are shown in
stick form, zinc and nucleophilic water as red and beige spheres, respectively. (C) Ninety degree rotation of the molecule in (B). (D) Electrostatic surface
representation of StcE in the same orientation as in (C), colored from 4 kT/e (red, negative) to +4 kT/e (blue, positive) using APBS (Baker et al., 2001).
(E and F) The molecule in (D) is rotated 90 and 180, respectively.
Structure
Structure of the StcE Mucinaseportions of INS, resulting in a large buried surface area of
3,955 A˚2 (Figures 1B and 1C). A partially resolved region, resi-
dues 679–798 (D2), docks against M on the opposite face of the
active site. Viewing toward the active site, the D2 region and
domains M and IG are approximately coplanar with a long axis
of 80 A˚ (Figure 1B). Extending in opposite directions away
from this axis are disordered structural elements, INS and D1,
spanning Arg578-Arg676 (as judged by residual density and
weak anomalous signals likely reflecting SeMet594, 598, and
608 in region D1). This unique arrangement of distinct, noncata-
lytic domains observed around the metalloprotease domain
likely allows for additional regulatory functions including sub-
strate recognition. The chain terminates in domain C (Glu804-
Lys898), which is tethered to D2 through a short linker and
adopts a b/g crystalline fold. This domain is located 180
from the active site and makes minimal contact with rest of the
protein.
The electrostatic surface potential of StcE calculated based
on our crystal structure reveals a highly polarized charge distri-
bution for the metalloprotease (Figures 1D–1F). Specifically,Structure 20a large electronegative surface exists on one face of the mole-
cule, contiguous along the three domains IG, M, and C. In
contrast, the opposite plane is primarily electropositive and
hydrophobic. We suggest the uneven charge distribution likely
plays a role in substrate targeting at the host-pathogen interface.
This is reminiscent of the electrostatic features utilized by the
carbohydrate-binding sialidase/trans-sialidase family. Charge
repulsion from the electronegative face is believed to orient
the more electropositive substrate-binding site toward the
negatively charged glycoconjugate substrates and to facilitate
reversible binding (Luo et al., 1998).
Metalloprotease Domain
StcE possesses the extended zinc-binding motif HExxHxxGxxH
within its catalytic domain (Glu296-Val550), the boundaries of
which were ambiguous from sequence analysis and are now
clearly defined in our crystal structure. Overall, domain M adopts
a characteristic mixed a+b fold and a conserved Met-turn (StcE
Met518), features that place it within themetzincin superfamily of
metalloproteases including astacins, ADAMs (a disintegrin and, 707–717, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 709
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Figure 2. StcE Active Site
(A) Superposition of the StcE metalloprotease domain, in green, with related
metzincins (yellow, PDB 1IAG with a Z-score of 6.4; wheat, 2ERO, 6.5; blue,
2DW2, 6.8) along the active site helix. The wider angular opening between
M-SD1 and M-SD2 in StcE is believed to accommodate large, densely
O-glycosylated substrates. The catalytic zinc ion is shown as a red sphere.
(B) Structural elements known to mediate substrate binding in metzincins are
highlighted in green. The active site flap in red is unique to StcE. Note the high
curvature in the strand preceding S4. Catalytic residues are shown in stick
form, zinc as a red sphere, and nucleophilic water as a beige sphere.
(C) Orientation of StcE is identical to the molecule in (B). Conserved structural
motifs potentially involved in substrate binding and transition state stabilization
surround the catalytic residues. Black dashed line delineates the proposed S1
pocket. Green dashed lines represent hydrogen bonds.
(D) Docking of the C1-INH tripeptide, T111DS, in the active site. StcE surface is
colored by residue type, with cyan being polar; blue, basic; red, acidic; pink,
aromatic and grey, hydrophobic. The catalytic zinc ion is shown as an orange
sphere. Dashed green line outlines the proposed sugar-binding site.
See also Figure S3.
Structure
Structure of the StcE Mucinasemetalloprotease), and matrixins (reviewed in Gomis-Ru¨th, 2009).
Notably, a central substrate-binding cleft containing the active
site separates this domain into two subdomains M-SD1 and
M-SD2 (Figures 1C and 2A). M-SD1 consists of a twisted b sheet
(order b6, b2, b1, b3, b5, b4) packed on both sides by three
helices (H1–H3). A sharp turn introduced by the conserved
Gly453 in the zinc-binding motif along the active site helix (H3)
then leads to M-SD2, which, after a series of convoluted loops,
terminates in H4. In addition to the metzincin-like topology,
StcE contains unique structural elements that may have evolved
to allow cleavage of densely O-glycosylated substrates. In
related single-domain zinc metalloproteases, namely thermoly-
sin and astacin, ligand-binding triggers closure of the ligand-
free, open conformation via subdomain motion and reorients710 Structure 20, 707–717, April 4, 2012 ª2012 Elsevier Ltd All rightsthe active site residues for catalysis (Grams et al., 1996; Holland
et al., 1992). Overlay of StcE with structurally homologous
metzincins shows the former to have an active site cleft with
a wider angular spacing in the analogous ‘‘open’’ conformation
(Figure 2A). The relative orientation of M-SD1 and M-SD2 is
10 wider in StcE (see Experimental Procedures), as is the
spacing between corresponding elements known to recognize
primed-side residues of the substrate via b strand-like hydrogen
bonds. These include structural elements connecting S3 and S4,
which exhibit unusually high curvature in StcE and a variable
loop joining the conserved methionine (StcE Met518) and helix
H4 in M-SD2 (Figure 2B). Furthermore, the M-SD2 variable
region (Leu454-Thr534) is considerably more elaborate (in orga-
nization and length) than those typically observed in metzincins,
forming a large, concave surface toward the catalytic center
(Figures 1C and 2A). Collectively, these features may have
evolved to facilitate approach by the expanded dimensions
and ‘‘bottle brush’’-like structures of densely glycosylated
mucin-like substrates, including C1-INH, CD43, and CD45 (Cys-
ter et al., 1991; reviewed in Holmes, 2006; Perkins et al., 1990).
Catalytic Site and Implications for Substrate Specificity
Although sequence identity is limited among metzincins, struc-
tural superposition of StcE with other members of the family
reveals a number of conserved catalytic residues. The essential
zinc ion is coordinated in the characteristic tetrahedral fashion by
His446 and His450 on the active site helix (H3), His456, and a
water molecule (Figure 2C). Met518 in the conserved Met-turn
forms the hydrophobic base of the active site. In our crystal
structure, Asp447 has been substituted for the Glu general
base in wild-type (WT) StcE to facilitate crystallization. Being
one methylene unit shorter, Asp447 is 5 A˚ away from the
observed nucleophilic water, thus consistent with the inability
of this mutant to hydrolyze substrates (Lathem et al., 2002).
In all metzincin clan members structurally characterized to
date, S4 in the twisted b sheet forms the upper rim of the active
site cleft and binds primarily to the nonprimed end of the
substrate in an antiparallel fashion (reviewed in Gomis-Ru¨th,
2009). In StcE, a stretch of conserved glycines, from Gly426 to
Gly432 with an internal Ser428, occurs along S4 (Figures 2B
and 2C). The poly-Gly motif likely confers plasticity to the active
site cleft, allowing StcE to cleave substrates with somewhat lax
specificity preferences. This structural featuremay explain why it
has been difficult to identify a consensus sequence among the
glycosylated PTS-rich regions of StcE substrates (Szabady
et al., 2011). Due to intramolecular interactions between the
a-O-linked GalNAc and the peptide core (Coltart et al., 2002),
the O-glycan clusters constrain the mucin-like peptide chain
into a specific, extended conformation (reviewed in Jentoft,
1990). High conformational freedom of the poly-Gly backbone
likely facilitates recognition of the O-glycan induced conforma-
tion. Indeed, the phi and psi angles of the well-ordered Gly426
and 430 lie in less favorable regions of the Ramachandran plot
(data not shown). Immediately upstream of H2 is a flap contain-
ing the strictly conserved Trp366 and His367 (Figures 2B and
2C). Their side chains project into and constrict the active site,
providing some level of subsite specificity. Importantly, the
backbone orientation of this flap is held in position via hydrogen
bonding by several invariant residues, namely, Gly426 of thereserved
AB
Figure 3. Mammalian Glycan Array
Screening of StcED35E447D
(A) Chemical structure of the highest affinity
ligand,Neu5Aca2-3Galb1-3(Neu5Aca2-6)GalNAca-
threonine.
(B) The strength of binding for each glycan array
target represented on the x-axis is proportional to
the measured fluorescent intensity (shown on the
y-axis). Note the preferential binding of StcE to the
O-glycan in (A) over a similar ligand substituted
with the aliphatic linker -CH2CH2CH2CH2-. The
error bar associated with each fluorescence signal
measurement refers to the standard error of
the mean.
Structure
Structure of the StcE Mucinasepoly-Gly strand, Arg372, and His425 side chains, which are
further stabilized by the phenyl ring of Tyr418 (Figure 2C). By
virtue of its proximity to the active site, His 367 may be involved
in stabilizing the carboxyanionic transition state in addition to
substrate binding. Tyr457 located downstream of the zinc ligand
His456 could potentially fulfill a similar role (Figure 2C). The
residue is strongly though not strictly conserved among M66
members (Figure S2). It may undergo a ‘‘tyrosine switch’’ or shift
in position associated with substrate and/or transition state
stabilization analogous to other family-specific nonzinc-binding
tyrosines in this position (reviewed in Gomis-Ru¨th, 2003).
StcE/C1-Esterase Inhibitor Interaction
StcE has been shown to specifically require interaction with
O-glycosylated regions of its substrates (Lathem et al., 2004;
Szabady et al., 2009); however, little is known about the mode
of interaction and substrate recognition sequence. We have
chosen the commercially available C1-INH as our model
substrate as it is more amenable to biochemical characterization
than the membrane-associated mucin-type substrates CD43
and CD45. We were able to trap a complex of StcE bound to
humanC1-INHusing the inactive E447Dmutant. Static light anal-
ysis of the resulting metalloprotease/serpin complex revealed
a1:1 binding stoichiometry (FiguresS1B–S1D).We tried to define
the binding interface in more detail by X-ray crystallographic
approaches. However, various attempts to obtain a high-resolu-
tion structure of the complex were unsuccessful, likely due to the
inherent structural heterogeneity of O-glycosylated C1-INH.
To further probe the substrate specificity of StcE, we next
sought to identify the cleavage site by N-terminal sequencing
of the StcE-treated C1-INH fragment, which has an apparent
molecular weight (60–65 kDa) comparable to that reported in
the literature (Lathem et al., 2002). The resulting primed-side
residues match closely to S113PTQP in the published sequenceStructure 20, 707–717, April 4, 2012except the T115L substitution (Fig-
ure S1A), possibly representing a se-
quence variant. The cleavage occurred
within the O-glycosylated N-terminal
region of C1-INH, in agreement with the
fact that its C-terminal serpin domain
remains active upon StcE binding
(Lathem et al., 2004). N-terminal to the
scissile bond, the P1 residue Asp112 of
C1-INH could conceivably fit in a shallowpocket created by the invariant His367, Arg372, and Lys377 (Fig-
ure 2C). We attempted to fit the C1-INH tripeptide spanning P2-
P1’ (T111DS) into the StcE active site by docking (Trott andOlson,
2010), and the accepted, energy-minimized conformation of the
docked ligand shows a reasonable bindingmode with respect to
the surrounding catalytic residues (Figure 2D). To further identify
potential carbohydrate moieties that StcE recognizes, we sub-
jected the full-length protease to mammalian glycan array anal-
ysis. The screen revealed Neu5Aca2-3Galb1-3(Neu5Aca2-6)
GalNAca-threonine as the top ligand (Figures 3A and 3B) (see
Discussion).
Curiously, the poorly resolved density corresponding to the
INS region (Lys150-Ser245) appears to approach the active
site (Figure 1B). We generated a truncation mutant of this se-
quence-variable region (DINS) (Figure S2) to test its involvement
in substrate binding. DINS exhibited decreased proteolytic
activity toward C1-INH compared to WT StcE (Figure 4A)
(circular dichroism spectrum confirmed no large perturbation
to the overall structure due to the mutation, as shown in Figures
4B and 4C). This suggests the insertion may contribute to
substrate binding and specificity although we cannot exclude
the possibility of additional sequence determinants in the
absence of a complete structure. Region INS has a propensity
to form primarily b strands according to secondary structure
prediction (Cole et al., 2008). The fact that we did not observe
well-ordered density for INS in our model suggests this region
may adopt multiple conformations that contribute to the ability
of StcE to capture a variety of complex substrates at the cell
surface. To explore this hypothesis further, we solved the struc-
ture of the isolated INS domain using an iodide soak SIRAS tech-
nique. Indeed, domain INS folds independently as a mixed,
eight-stranded b sandwich with homology to the T4 bacterio-
phage structural protein gp9 (Z-score of 6.2) and contains an
additional b strand followed by a perpendicular arrangement ofª2012 Elsevier Ltd All rights reserved 711
Figure 4. Biochemical Characterization of StcE Domain Variants
(A) Time-dependent proteolytic cleavage of C1-INH byWTStcE, C-terminal truncation (DC) and insertion deletion (DINS) mutants. Time wasmeasured inminutes
unless otherwise indicated (hour, hr). Relevant lanes were assembled from multiple SDS-PAGE gels.
(B) Circular dichroism analysis of WT StcE and DINS. The deletion mutant retained secondary structure elements; its impaired proteolytic efficiency was not due
to misfolding.
(C) Gel filtration elution profiles of monomeric WT StcE (blue) and DINS (red). SDS-PAGE analysis of respective peak fractions is shown in the inset.
(D) Cellular localization analysis of the outer membrane protein control ZirT using increasing concentrations of sucrose (30% to 55%), as denoted by the gradient
above the SDS-PAGE gel.
(E) Sucrose density gradient analysis of WT StcE and its C-terminal truncation mutant (StcEDC) revealed a reduced amount of DC in the OMP fractions. The
decrease was unlikely due to poor expression of StcEDC as similar levels of WT StcE and themutant were present in their respective total lysates in lanes 1 and 2.
See also Figure S1.
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Structure of the StcE Mucinasetwo a helices in its N-terminal region. We then positioned the
compact module in the context of the existing model to obtain
a more complete description of the StcE structure and function
(correct placement was confirmed by the anomalous signal of
SeMet205). A long loop (His132-Lys150) links the N terminus of
INS to domain IG and provides flexibility, placing the putative
exosite domain 35 A˚ away from the catalytic center in our
model (Figure 5A). A set of electropositive surface patches and
a conserved cluster of solvent-exposed Trp189, Arg191 and
Tyr214, which appear suitable for glycoprotein binding, tilt
toward the active site (Figures 5B and 5C). Being flexibly linked,
domain INS may exist in various conformations to present
a potential protein-binding interface relative to its respective
targets.712 Structure 20, 707–717, April 4, 2012 ª2012 Elsevier Ltd All rightsCell Surface Binding Features
StcE protects serum-sensitive E. coli from complement-medi-
ated lysis by recruiting C1-INH to an opsonized, or antibody-
coated cell surface, effectively increasing C1-INH local concen-
trations. The process requires direct interaction between the
cells and StcE, as confirmed by flow cytometry analysis (Lathem
et al., 2004), although the mechanism of surface localization is
unclear. Structural homology search by DALI (Holm and Rose-
nstro¨m, 2010) suggests StcE’s C-terminal domain may, in part,
mediate such an interaction. The bg-crystallin fold domain
shows the highest similarity with protein S (Protein Data Bank
[PDB] 1NPS, Z-score of 9.2 and rmsd of 2.4 A˚ over 77 aligned
Ca), a surface coat protein that assembles around myxospores
of Myxococcus xanthus during periods of cellular stress (Inouyereserved
Figure 5. Relative Orientation of the Proposed Exosite Domain in StcE
(A) Position of domain INS in the overall StcE structure, shown in the same orientation as in Figure 1B. The conserved Trp189, Arg191, and Tyr214 potentially
involved in carbohydrate binding are in yellow stick form.
(B) Electrostatic surface potential of the molecule in (A), colored from4 kT/e (red, negative) to +4 kT/e (blue, positive). The conserved cluster containing solvent-
accessible Trp189, Arg191, and Tyr214 is shaded in yellow.
(C) 180 rotation of the molecule in (B) reveals surface charge asymmetry in domain INS.
See also Figure S2.
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Structure of the StcE Mucinaseet al., 1979). We evaluated the ability of the C-terminal domain to
associate peripherally with the cell surface by comparing the
cellular localization of WT StcE and its truncation mutant (DC)
in an equilibrium sucrose density experiment.WT StcE cofractio-
nated with the outer membrane protein (OMP) control ZirT
(Gal-Mor et al., 2008) while significantly less of DC remained in
the corresponding fractions (Figures 4D and 4E). Indeed, the
calculated electrostatic surface of StcE reveals electropositive
clusters and hydrophobic ridges in domain C that may provide
complimentary charges for surface association (Figure 1E).
Proteolytic efficiency of DC is comparable to the WT (Figure 4A),
indicating the domain is dispensable for substrate binding.
DISCUSSION
StcE-like enzymes comprise theM66metalloprotease family, for
which only EHEC StcE and TagA orthologs from A. hydrophila
(Pillai et al., 2006) and V. cholera have been characterized
biochemically (Szabady et al., 2011), and no members structur-
ally. As such, the StcE structure described here provides a foun-
dation for understanding this family, including the molecular
features that govern the critical mucinase action used to over-
come the host innate immune response to bacterial infection.
We suggest the unusually open dimensions of the StcE sub-
strate-binding cleft compared to other metzincins may reflect
its unique ability to efficiently process large O-glycosylated
substrates. In addition, the observed surface charge asymmetry
in StcE likely has an impact on how the protease approaches
its substrates. a-O-glycan clusters found along PTS-tandem
repeats of mucin-type host glycoproteins impart an overall nega-
tive charge to the molecules. Of note, the predominately acidic
face of StcE may provide charge repulsion that suitably orients
the more electropositive target binding site toward surface
localized substrates on the host cell, a strategy also adopted by
members of the carbohydrate-binding sialidase/trans-sialidase
family. We suggest these properties might have evolved to allow
StcE toovercome theelectrostatic shieldingandgeneral protease
resistance afforded by O-glycosylated proteins (Garner et al.,Structure 202001). Measuring 8 A˚ in width at the most narrow constriction,
the StcE active site cleft widens further away from the catalytic
center on both the primed and nonprimed ends (Figure 2D). This
allows the protease to form optimal interactions at the scissile
peptidebondwhileminimizingstericclasheswithpotential carbo-
hydrate moieties linked to peptide residues nearby. These overall
features, together with conserved structural motifs identified in
the catalytic domain allow us to describe a probable mechanism
for StcE’s specificity toward mucin-type substrates.
When StcE is in the open conformation, O-glycoprotein sub-
strates such as C1 esterase inhibitor (C1-INH) can access the
clamp-like opening between M-SD1 and M-SD2 of the metallo-
protease domain and be captured by StcE. A basic S1 specificity
pocket formed by the conserved His367, Arg372, and Lys377
indicates a preference for acidic residues in this subsite of the
enzyme active site. As shown by the interactions simulated by
our characterized C1-INH peptide spanning P2-P1’ (T111DS),
fitting of Asp112 at P1 is sterically and electrostatically compat-
ible (Figure 2D). The bulky side chains of Trp366 and His367 in
the conserved G364GWHSG flap partially shield the active site
from bulk solvent, increasing the local effective charge, particu-
larly for electrostatic interactions in the S1 subsite (Figures 2C
and 2D). Sequence analysis of C1-INH identified 14 potential
O-glycosylation sites (Bock et al., 1986), including Thr111, which
would fit as P2. Although the sugar moiety attached to Thr111
has yet to be verified experimentally, aromatic side chains of
the nearby Tyr404 and Phe544 can potentially mediate carbohy-
drate binding through stacking interactions, a common theme in
sugar binding (Figure 2D).
Our mammalian glycan microarray analysis of StcE iden-
tified the disialylated core I O-glycan Neu5Aca2-3Galb1-3
(Neu5Aca2-6)GalNAca-threonine as the highest affinity ligand
(Figure 3A). Previous lectin-binding assays have also confirmed
the presence of similarly linked sugars on C1-INH (Schoen-
berger, 1992). Interestingly, substitution of the threonine in this
glycoconjugate with the extended -CH2CH2CH2CH2- linker
abrogates binding (Figure 3B), suggesting ligand recognition
involves both the peptide and sugar moiety. Welch et al., 707–717, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 713
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Structure of the StcE Mucinaseconducted a similar glycan array study and obtained different
results that were reported to be inconclusive (available in
a searchable public database on the Center for Functional
Glycomics website http://www.functionalglycomics.org/static/
consortium/links2Website.shtml). We acknowledge that we
used the full-length StcE for our screen instead of a truncated
version used in the other study and hypothesize that ligand
binding requires cooperative interaction between the different
StcEmodules observed in our structure. Moreover, conservation
of the poly-Glymotif in StcE, as well as Gly520 andGly521 on the
rims of the active site cleft indicates that conformational flexibility
is essential for catalysis (Figures 2B and 2C). The glycine back-
bone can assume a wider range of torsional angles without
undue strain, allowing the active site to adapt to and recognize
specific a-O-glycan induced conformations inmucin-type glyco-
protein substrates. Indeed, evidence from high-resolution NMR
analysis of mucin glycopeptides based on the StcE substrate
CD43, revealed a stable conformation arising from the interac-
tion of a-O-GalNAc with adjoining peptide functional groups
(Coltart et al., 2002). Specifically, the GalNAc amide proton
hydrogen bonds to the glycosidic oxygen and the backbone
carbonyl of the attached amino acid, while the hydrophobic
face of the N-acetyl methyl forms medium-range interactions
withmethyl groups of the peptide side chain two positions down-
stream from the site of O-glycosylation. (Hashimoto et al., 2011).
While the electrostatic profile and open conformation of the
StcE active site facilitates substrate approach, we speculate
that substrate binding could trigger domain closure through
induced-fit, leading to favorable protease-substrate interac-
tions. Mutagenesis studies on the related thermolysin-like prote-
ases (TLP) suggest that conserved glycines are involved in
hinge-bending motions associated with closure and opening of
the binding cleft during catalysis (Veltman et al., 1998). Interest-
ingly, Gly441 of StcE lies in a structurally analogous position at
the N-terminal end of the interdomain active site helix as the
conserved Gly136 of TLP (Figure S2). The residue may mediate
a similar hinge-like movement that optimally orients StcE and
the target peptide toward one another.
Orientation of the docked C1-INH peptide in the StcE active
site, with the P1 carbonyl within binding distance of the metal,
allows for nucleophilic attack by the zinc-bound water on the
re-face of the scissile peptide bond (Figure 2D). This is consistent
with the catalytic register and substrate-binding mode of similar
metzincins (reviewed in Gomis-Ru¨th, 2009). His367 and/or the
nonligandingTyr457 could potentially stabilize the transient
negative charge on the tetrahedral intermediate, contributing
to the charge neutralization effect of the catalytic zinc cation
nearby. This likely requires reorientation of the Tyr457-contain-
ing loop and rotation of the residue side chain to bring the
phenolic hydroxyl into proximity, in a ‘‘tyrosine switch’’ motion
observed in the related snapalysins (Kurisu et al., 1997). After
hydrolysis, the cleaved target is liberated from the active site
and the protease regenerated.
Despite extensive conserved surface features in the active site
(Figure S3) and their shared specificity towardmucin-type glyco-
proteins, substrate profiles of StcE homologs characterized to
date are not identical. In particular, the Vibrio pathogenicity
island-encoded virulence factor TagA, which shares 37%
sequence identity with StcE, cleaves CD43 less efficiently714 Structure 20, 707–717, April 4, 2012 ª2012 Elsevier Ltd All rightscompared to StcE and is inactive toward C1-INH (Szabady
et al., 2011). This suggests that sequence divergence between
these proteins may be responsible for differences in substrate
preference. We hypothesize that a dynamic, sequence-variable
region (INS, His132-Asn251) within the N-terminal IG domain,
which likely has arisen from a gene insertion event, contributes
to substrate specificity. The INS domain structure, which we
solved separately, reveals complimentary surface features that
are oriented toward the active site, indicating a possible exosite
role for specifying binding partners as in the metalloprotease
RVV-X (Takeda et al., 2007) (Figures 5A–5C). This is supported
by our observed decrease in cleavage efficiency of DINS toward
C1-INH. We speculate that StcE has evolved this modular archi-
tecture to fine-tune its substrate binding. Though present inmost
StcE-like proteins in the M66 family, select members lack this
insertion element (for instance, EEZ85628 and EDL70231 from
the marine bacteria Vibrio harveyi 1DA3 and HYf1, respectively)
and instead, feature tandem chitin/cellulose-binding domains
in the C termini as annotated in the Entrez protein sequence
database (Figure S2). The variation in domain composition and
organization likely reflects adaptation to changing substrate
motifs in different host environments (Pruzzo et al., 2008). Trun-
cation mutants and chimeric proteins designed based on the
StcE model will provide insight in that regard.
The StcE structure reveals how the M66 peptidase family can
acquire noncatalytic domains potentially conferring distinct
substrate specificities while preserving essential features of its
catalytic scaffold. The overall conformation of StcE and local
flexibility in the active site appear to have evolved to specifically
recognize O-glycan induced conformations inmucin-type glyco-
proteins. The findings provide a structural basis for under-
standing how bacterial virulence factors can breach themucosal
barrier and disarm key host immune proteins and specifically
represent a highly attractive, accessible antimicrobial target to
block enterohemorrhagic virulence and disease. Owing to its
ability to cleave select mucins, StcE has also been proposed
as a treatment for cystic fibrosis and shown to loosen the mucus
in affected patients (US patent no. 7214479). The model pre-
sented here may also facilitate the design of new therapeutics
for this devastating respiratory disease.EXPERIMENTAL PROCEDURES
Cloning
The gene encoding Escherichia coliO157:H7 stcE residues 36–989 (accession
code: O82882) was amplified from genomic DNA using the primers 50-CCG
CAGGCTAGCGCTGATAATAATTCAGCC-30 and 50-CCGCAGCTCGAGTTATT
TATATACAACCCTCATTGACC-30. The PCR product was ligated into NheI and
XhoI sites of pET28b expression vector (Novagen). The pET28bstcED35
construct served as a template for all subsequent StcE variants. 50-GGGAATG
AGTTCAGTCATGACGTTGGTCATAATTATGG-30 and 50-CCATAATTATGACC
AACGTCATGACTGAACTCATTCCC-30 were used to introduce the E447D
mutation by QuickChange (Stratagene). The surface entropy reduction mutant
K318A/K320A/E321A was generated by the same procedure with 50-CGGG
ATCGCTTTGATTTTGCCGCAGACGCAGCAGCACATAGGG-30 and 50-CCCT
ATGTGCTGCTGCGTCTGCGGCAAAATCAAAGCGATCCCG-30. The insertion
deletion (DG140-F243) was chosen to be consistent with the StcE model
and secondary structure prediction and removed by QuickChange using
50-GGATGGTGTTCCGGAAGGTCGCTCCGGTGAACTGGAG and 50-CTCCA
GTTCACCGGAGCGACCTTCCGGAACACCATCC. Domain INS (H132-N251)
was cloned using 50-CCGCAGGCTAGCCATCTGGATGGTGTTCCGGAAG-30reserved
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Structure of the StcE Mucinaseand 50- CCGCAGCTCGAGTTAATTATTCTCCAGTTCACCGGAG-30. All con-
structs were confirmed by sequencing.
Protein Expression and Purification
E. coli BL21 (lDE3) transformed with stcE variants was grown at 37C until
midexponential phase and protein production was induced with 0.3 mM
IPTG at 20C overnight. Harvested cells were disrupted by a pressurized
homogenizer (Avestin) in lysis buffer (20 mM HEPES [pH 7.5] and 500 mM
NaCl). The clarified lysate containing the target protein was purified sequen-
tially by zinc-chelating Sepharose, MonoQ anion-exchange and Superdex-
200 HR 10/30 columns (GE Healthcare) to >95% purity as judged by SDS-
PAGE. The affinity tag was cleaved with thrombin prior to size exclusion and
the protein stored in 20 mM HEPES (pH 7.5) and 150 mM NaCl.
Crystallization and Data Collection
Initial needle clusters were obtained from StcED35E447D. After various
attempts to improve the diffraction quality, larger crystals of the quadruple
mutant K318A/K320A/E321A/E447Dwere grown by the hanging-dropmethod
at 18C. The drops consisted of a 1:1 ratio of StcE (7 mg.ml-1) and the reservoir
solution (0.2 M MgCl2, 8% PEG8000, and 0.1 M MES [pH 6.5]). Crystals of
domain INS were obtained with 26% PEG2000MME and 0.1M trisodium
citrate (pH 5.5) and derivatized with 0.5 M NaI for halide phasing. Single crys-
tals were cryoprotected by briefly soaking in the mother liquor supplemented
with 25% glycerol and flash-frozen in liquid nitrogen. Since most of the
quadruple mutant crystals exhibited anisotropy, extensive screening was
done at the Canadian Light Source 08ID-1 beamline before sufficient diffrac-
tion was obtained from a SeMet derivative. Data were collected at the sele-
nium peak (0.97907 A˚) and processed using MOSFLM (Battye et al., 2011)
and SCALA (Collaborative Computational Project, Number 4, 1994).
Structure Determination and Refinement
Initial experimental phaseswere obtained bySHARPof the automatic structure
solution program autoSHARP (Vonrhein et al., 2007), which located 10 out
of a possible 17 selenium sites. Subsequent solvent flipping with SOLOMON
from autoSHARP resulted in a reasonably interpretable map for the core of
StcE. The model was built manually using Coot (Emsley et al., 2010). Iterative
rounds of refinement were performed using REFMAC (Murshudov et al.,
1997) with TLS (translation/libration/screw) (Painter and Merritt, 2006), and
BUSTER (Blanc et al., 2004) to improve modeling of the poorly resolved
regions. The TLS parameters were generated by the TLSmotion determination
server, which modeled the flexible StcE structure as contiguous groups of
atoms undergoing rigid-body motion. The optimal TLS groups, as judged by
the diminishing net TLS residual, are composed of residues 39–115, 116–139
and 248–310, 311–411, 412–512, 513–519, 520–685, 686–800, and 801–898.
The high Wilson B (61 A˚2) and overall refined B (83 A˚2) are perhaps not
surprising, given the modular and dynamic nature of StcE. Asn856, which is
located in a turn in domain C, lies in a disallowed region of the Ramachandran
plot in addition to Ala41 in the poorly resolved N terminus. Initial iodide phases
for domain INS were also obtained using autoSHARP. Following similar proce-
dures formodel building and refinement, its orientation in the overall StcE struc-
ture was determined by spherically averaged phased translation using SeMet
phases from the quadruple mutant. We compared the relative orientation
between M-SD1 and M-SD2 among StcE homologs by measuring the angle
between structurally equivalent residues (Ca of 3UJZ, R372/H446/P535;
1IAG, S71/H142/D180; 2ERO, T267/H335/D373; 2DW2, A263/H333/N371).
Structure figures were prepared with PyMol (http://pymol.sourceforge.net).
The ConSurf server was used to identify functionally and structurally important
residues (Glaser et al., 2003; Landau et al., 2005).
Static Light Scattering
Protein samples (0.5–1 mg.ml-1) were injected onto a Superdex-200 column
connected in line to a miniDAWN multiangle light scattering machine with an
interferometric refractometer (Wyatt Technologies). The associated ASTRA
software was used to estimate molecular mass for the data analysis.
Peptide docking
Molecular dockingwas performedwith AutoDock Vina, using default values for
the docking parameter file (Trott and Olson, 2010). The program merged allStructure 20nonpolar hydrogens and assigned charges to the atoms in the coordinate files.
A grid box of 22 3 22 3 18 grid points of 1 A˚ spacing covering the immediate
active site region was defined as the search space. Docking results were
manually inspected for structural and chemical complementarities. One of
the evaluation criteria was that the distance between zinc and the P1 carbonyl
oxygen be less than 3 A˚.
Proteolytic Assay
StcE variants were incubated with C1-INH (Molecular Innovations) in a 1:20
(wt/wt) ratio in 20mMHEPES (pH 7.5) and 150mMNaCl at 37C. Tenmicroliter
aliquots were removed from the 100 ml total assay volume at 0, 15, 45, 150,
240, and 360 min, 23 hr, and 48 hr, and the reaction was terminated with
EDTA (final concentration 50 mM). Bands corresponding to C1-INH were visu-
alized using Pro-Q Emerald 300 glycoprotein stain (Molecular Probes).
Sucrose Density Gradient Centrifugation
Pellets from 200 ml cultures of E. coli BL21 (lDE3) expressing StcE
variants were lysed by a pressurized homogenizer in buffer A (20 mM Tris
[pH 7.5]). Cell debris was removed by a low-speed spin at 10,000 3 g
(JA10 rotor, Beckman), followed by a high-speed spin at 140,000 3 g (Ti60
rotor, Beckman) to isolate the total membranes. The membrane pellet was
washed in buffer A, centrifuged again and homogenized in 2 ml buffer A.
Membrane fragments were then layered onto the sucrose gradient consisting
of 0.8 ml 55%, 2 ml 50%, 2 ml 45%, 2 ml 35%, and 0.8 ml 30% and
centrifuged in a SW41 swinging-bucket rotor (Beckman) at 180,000 3 g
for 16 hr.
Circular Dichroism Spectroscopy
CD spectra of 0.25 mg.ml-1 WT StcE and mutant devoid of the insertion
element were recorded in a Jasco J-810 spectropolarimeter at 25C. All
spectra were the average of four scans. The optical path length is 0.1 cm.
Glycan Array Screening
The glycan array-binding analysis was performed at the Consortium for
Functional Glycomics (http://www.functionalglycomics.org/static/index.
shtml). StcED35E447D, fluorescently labeled with the Alexa Fluor 488 dye
(Molecular Probes), was screened with version 4.2 of the printed mammalian
glycan microarray containing 511 ligands in replicates of 6. The highest and
lowest fluorescence readings were excluded from statistical analysis of the
data in an attempt to eliminate false hits.
ACCESSION NUMBERS
The structure factors and coordinates have been deposited in the Protein Data
Bank under accession codes 3UJZ and 4DNY.
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